Holger J Schünemann, MD, PhD

Research Professor, Department of Social and Preventive Medicine

Contact Information

McMaster University
Hamilton, Ontario, Canada
Phone: 905-525-9140 x24931
Fax: 443-339-0565
Email: schuneh@mcmaster.ca

Faculty Links

Research Interests: evidence based medicine, presenting evidence, measuring health related quality of life, levels of evidence, strength of recommendations, guidelines, lung function, nutrition and oxidative stress, decision making COPD

Selected Publications

  • Schünemann HJ, Hill S,  Kakad M, Vist G, Bellamy R, Stockman L,Uyeki T, Del Mar C, Shindo N, Fukuda K, Hayden F, Yazdanpanah Y,Oxman, AD: Transparent Development of the WHO Rapid Advice Guidelines. PLoS Medicine (in press) 2007
  • Schünemann HJ, Hill S,  Kakad M, Bellamy R, Uyeki T, Hayden F, Yazdanpanah Y, Beigel J, Chotpitayasunondh T, Vist G, Del Mar C, Farrar J, Fukuda K, Hien TT, Shindo N, Stockman L, Sugaya N, Tomson G, Nagjdaliyev A, Özbay B, Roth C, Croisier A, Oxman, AD: WHO Rapid Advice Guidelines for the pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. The Lancet Infectious Disease 7:21-31, 2007
  • Stanulla M, Schünemann HJ: Thioguanine versus mercaptopurine in childhood ALL. Lancet 2006, 368(9544):1304-1306.
  • Puhan MA, Busching G, Schunemann HJ, VanOort E, Zaugg C, Frey M: Interval versus continuous high-intensity exercise in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2006, 145(11):816-825.
  • Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, Fahy BF, Gould MK, Horan KL, Krishnan JA et al: An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006, 174(5):605-614.
  • Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, Trevisan M, Iacoviello L, Cassano PA, Schünemann HJ: Oxidative stress and pulmonary function in the general population. Am J Epidemiol 2005, 162(12):1137-1145.
  • Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse JW, Pacheco-Huergo V, Bryant D, Alonso J, Akl EA, Domingo-Salvany A, Mills E et al: Validity of composite end points in clinical trials. BMJ 2005, 330(7491):594-596.
  • Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, Lacchetti C, Leung TW, Darling E, Bryant DM et al: Randomized trials stopped early for benefit: a systematic review. JAMA 2005, 294(17):2203-2209.
  • Schünemann HJ, Cook D, Grimshaw J, Liberati A, Heffner J, Tapson V, Guyatt G: Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(3 Suppl):688S-696S.
  • Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D et al: Grading quality of evidence and strength of recommendations. BMJ 2004, 328(7454):1490.

revised: 2011.10.24